MDmetrix Helps Eliminate Opioids for Most Pediatric Outpatient Surgeries

SEATTLE, April 28, 2020 /PRNewswire/ -- MDmetrix, a clinical performance management company, announced today that its artificial intelligence (AI)-driven technology was a pivotal component in a joint initiative with Seattle Children's Hospital at its Bellevue Clinic and Surgery Center (BCSC) to develop the nation's first-ever "opioid-free" surgery center. Clinicians from BCSC recently published a groundbreaking study of their success in reducing opioid administration in the leading international anesthesia journal Anesthesia & Analgesia titled, "In Pursuit of an Opioid-Free Pediatric Ambulatory Surgery Center: A Quality Improvement Initiative."

"Across the country, 5% of adolescents who undergo surgery become persistent opioid users," said Greg Latham, MD, attending anesthesiologist at Seattle Children's Hospital. "Surgery is a critical gateway to opioid misuse, so this is a tremendous breakthrough. MDmetrix's technology allowed us to quickly implement evidence-based non-opioid alternatives, assess and adapt our anesthesia protocols, and dramatically improve care for our patients."

As a result of this joint initiative between MDmetrix and Seattle Children's, more than 6,000 pediatric patients at BCSC have successfully undergone opioid-free surgery. The new protocols use combinations of non-opioid multimodal pain medications such as dexmedetomidine, nonsteroidal anti-inflammatory drugs (NSAIDs) and regional anesthesia.

The MDmetrix Mission Control platform was used to visualize and evaluate outcomes data so that physicians could quickly adapt their protocols, incorporating evidence-based best practices, to effectively manage surgical pain while reducing patients' opioid exposure. After their initial success in implementing opioid-sparing protocols for tonsillectomy and adenoidectomy surgeries, BCSC expanded their approach to include other surgeries—and quickly learned they could eliminate opioids for most types of outpatient surgery.

Transforming Clinical Operations
As reported in the Anesthesia & Analgesia study, physicians at Seattle Children's used MDmetrix to analyze more than 10,700 surgical cases. Based on insight from MDmetrix, the physicians developed protocols that eliminated opioid administration during surgery from the vast majority of their outpatient procedures (dropping from 84% to 8% of procedures), while also reducing the need for postoperative morphine administration from 11% to just 6%. With these new protocols, the clinicians found that postoperative nausea and vomiting—commonly caused by opioid administration—virtually disappeared, while pain scores, total anesthesia time, and total post-anesthesia care unit (PACU) time remained stable. Overall, costs also decreased, while patient/parent satisfaction increased dramatically.

BCSC's quality improvement initiative with MDmetrix began in January 2018, with providers focusing on reduction of opioid administration in pediatric tonsillectomies, which have typically relied on the intraoperative administration of opioids for pain management. The anesthesiologists from BCSC assembled a team to utilize a series of pain management protocols following the Plan-Do-Study-Act (PDSA) cycle, which is the standard methodology for the development of clinical improvements using real-world data.

"Using MDmetrix, we have been able to accelerate our PDSA-driven improvement work at a pace far beyond traditional methodologies," Latham said. "With the MDmetrix Mission Control platform, we are improving protocols in weeks that we used to review across years. By enabling us to continuously monitor and evaluate outcomes across patients, MDmetrix has empowered our team to act on our data to implement a truly adaptive clinical management system."

The opioid-free surgery initiative at BCSC is just one example of how MDmetrix's clinical performance platform and AI tools are currently being used to transform clinical operations across hospitals and ambulatory surgery centers. Using the MDmetrix Mission Control platform, clinicians and healthcare leaders can visualize, compare, improve, and manage performance by team, protocol and/or facility across a wide array of metrics, including pain scores, procedure times and readmissions. As a result, providers have been empowered to transform patient care while also dramatically reducing resource utilization.

"We are thrilled that MDmetrix technology was used to drive this groundbreaking initiative to reduce patients' exposure to opioids," said Warren Ratliff, CEO of MDmetrix. "It is gratifying that our platform is being used to help keep kids safe."

About MDmetrix
MDmetrix is a clinical performance management platform that serves hospitals and surgery centers. By empowering medical leaders and frontline clinicians to visualize, evaluate and monitor clinical and workflow outcomes, MDmetrix enables providers to improve care and lower costs, transforming clinical operations. Founded in Seattle in 2016, MDmetrix was created by a team of clinicians who saw the need to view outcomes across patients to quickly advance care. To learn more, please visit www.mdmetrix.com.

MEDIA CONTACT:
Tara Stultz
Amendola Communications for MDmetrix
440-225-9595
[email protected]

SOURCE MDmetrix

Related Links

http://www.mdmetrix.com